You Are Here: Home > About Arthritis > Arthritis in the News


    Apply Filters Clear All
    supplement news article

    Apr 08

    Health Canada has initiated a safety review on tofacitinib
    Health Canada is informing Canadians and health care professionals that it is conducting a safety review of Xeljanz and Xeljanz XR (tofacitinib) after a clinical trial identified an increased risk of serious heart-related issues and cancer in trial participants.Xeljanz and Xeljanz XR (tofacitinib...
    Health Canada
    Load More